EDEN RESEARCH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.25 GBX | -2.30% |
|
0.00% | -26.09% |
| 31/01 | Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive Director | CI |
| 22/01 | Eden Research annual revenue to beat market consensus amid sales boost | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- Based on current prices, the company has particularly high valuation levels.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -26.09% | 28.99M | - | ||
| +19.30% | 39.76B | C | ||
| -.--% | 11.16B | - | B+ | |
| -1.90% | 7.56B | A | ||
| +2.38% | 6.62B | B- | ||
| -5.50% | 5.94B | B+ | ||
| -4.27% | 5.74B | B | ||
| -11.80% | 5.54B | - | C- | |
| +29.81% | 5.13B | B- | ||
| +10.65% | 3.89B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EDEN Stock
- Ratings Eden Research plc
